Inventor
William G. Kaelin, Jr.
Inventor
Boston, MA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07KPeptides12%
C12YEnzymes12%
C12NMicroorganisms or enzymes5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
A01KAnimal husbandry2%
PatentTitleYear
10,365,278Pharmaceuticals and methods for treating hypoxia and screening methods therefor201910,233,452Compositions and methods for increasing erythropoietin (EPO) production20199,766,240'Method of identifying a compound for treating a hypoxic or ischemic related disorder'20179,193,973'Compositions and methods for increasing erythropoietin (EPO) production'20158,809,011'HIFα hydroxylation assay'20147,985,563'HIFαprolyl hydroxylation assay'20117,919,274'Light-emitting fusion proteins and diagnostic and therapeutic methods therefor'20117,666,997'Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies'20107,361,463'Muteins of hypoxia inducible factor alpha and methods of use thereof'20087,176,345'Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor'20076,855,510'Pharmaceuticals and methods for treating hypoxia and screening methods therefor'20056,849,718'Muteins of hypoxia inducible factor alpha and methods of use thereof'20056,451,979'Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies'20025,981,723'Retinoblastoma-associated protein 1 CDNA'19995,759,803'Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2019Patents assigned to DANA FARBER CANCER INST INC (15)· patent assignee history
1998–2019Based in Boston, MA, US· patent location history
2014–2015Patents assigned to KAELIN JR WILLIAM G (2)· patent assignee history
2015Patents assigned to ALYNYLAM PHARMACEUTICALS INC (1)· patent assignee history
2015Patents assigned to BETTENCOURT BRIAN (1)· patent assignee history
2019Patents assigned to ALNYLAM PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DANA FARBER CANCER INST INC | 15 | 1998–2019 |
| KAELIN JR WILLIAM Gself | 2 | 2014–2015 |
| ALNYLAM PHARMACEUTICALS INC | 1 | 2019 |
| ALYNYLAM PHARMACEUTICALS INC | 1 | 2015 |
| BETTENCOURT BRIAN | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boston, Massachusetts, US | 15 | 1998–2019 |